Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2700 participants
OBSERVATIONAL
2019-12-02
2039-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PRESERVE-MITRAL Post-Market Registry
NCT03283722
Valvular Heart Disease Registry
NCT03488732
CoreValve Advance International Post Market Study
NCT01074658
Valved Graft PMCF Study
NCT04754217
Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAVI Outcome - (German Pilot)
NCT03570190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Valve Replacement and/or Repair Patients
Surgical Heart Valve Repair Products
Surgical heart valve repair products.
Surgical Heart Valve Replacement Products
Surgical heart valve replacement products.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical Heart Valve Repair Products
Surgical heart valve repair products.
Surgical Heart Valve Replacement Products
Surgical heart valve replacement products.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has or is intended to receive or be treated with an eligible product
3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
Exclusion Criteria
2. Patient prohibited from participation by local law
3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Surgery
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WellStar Kennestone Hospital
Marietta, Georgia, United States
University of Michigan
Ann Arbor, Michigan, United States
Mount Sinai Medical Center
New York, New York, United States
Saint Francis Hospital
Roslyn, New York, United States
Saint Josephs Hospital Health Center
Syracuse, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
University Hospitals Cleveland
Cleveland, Ohio, United States
University of Pittsburgh Medical Center UPMC Presbyterian
Pittsburgh, Pennsylvania, United States
Baylor St. Luke's Medical Center
Houston, Texas, United States
The Heart Hospital Plano
Plano, Texas, United States
Inova
Falls Church, Virginia, United States
Allgemeines Krankenhaus - Universitätskliniken Wien
Vienna, , Austria
UZ Leuven
Leuven, , Belgium
Hôpital Haut-Lévêque - CHU de Bordeaux
Pessac, , France
Schüchtermann-Klinik
Bad Rothenfelde, , Germany
Herzzentrum Dresden GmbH Universitätsklinik
Dresden, , Germany
Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Albertinen-Herz- und Gefäßzentrum
Hamburg, , Germany
Herzzentrum Leipzig
Leipzig, , Germany
Deutsches Herzzentrum München Klinik an der TU München
München, , Germany
Onassis Cardiac Surgery Center
Athens, , Greece
Ospedale Pasquinucci Massa
Massa, , Italy
IRCCS Policlinico
San Donato, , Italy
Leids Universitair Medisch Centrum
Leiden, , Netherlands
Hospital Regional Universitario Carlos Haya Málaga - Hospital General
Málaga, , Spain
Inselspital - Universitätsspital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Richard Myung, MD
Role: primary
Bolling Steven, MD
Role: primary
Ahmed El-Eshmawi, MD
Role: primary
Karikehalli Dilip, MD
Role: primary
Brittany Zwishchenberger, MD
Role: primary
Yasir Abu-Omar, MD
Role: primary
Johannes Bonatti, MD
Role: primary
Kenneth Liao, MD
Role: primary
Timothy George, MD
Role: primary
Eric Sarin, MD
Role: primary
Martin Andreas, Prof
Role: primary
Tom Verbelen, MD
Role: primary
Louis Labrousse, Prof
Role: primary
Nicolas Doll, Prof
Role: primary
Klaus Matschke, MD
Role: primary
Christina Ballazs, MD
Role: primary
Friedrich-Christian Rieβ, Prof
Role: primary
Michael Borger, MD
Role: primary
Keti Vitanova, MD
Role: primary
George Stavridis, MD
Role: primary
Marco Solinas, MD
Role: primary
Dr. Andrea Daprati
Role: primary
Jerry Braun, MD
Role: primary
Enrique Ruiz Alonso, Dr.
Role: primary
Matthias Siepe, Prof. Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDT18061SUR003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.